Inpart Logo
Campaign Preview

Phase I-Ready EGFR Exon 20 Insertion Inhibitor Programme [2026-08-03 09:28]

13 Days Left

Opportunity types being sought:

Biopharma Assets
Technologies
Research Projects
Header

Pipeline scoping test campaign content